Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(13%)
Results Posted
100%(6 trials)

Phase Distribution

Ph phase_3
8
100%

Phase Distribution

0

Early Stage

0

Mid Stage

8

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
8(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(6)

Detailed Status

Completed6
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 38 (100.0%)

Trials by Status

active_not_recruiting113%
not_yet_recruiting113%
completed675%

Recent Activity

1 active trials
Showing 5 of 8
not_yet_recruitingphase_3

Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

NCT06750458
active_not_recruitingphase_3

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

NCT05505994
completedphase_3

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

NCT02518945
completedphase_3

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

NCT02725593
completedphase_3

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

NCT01095666
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06750458Phase 3

Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

Not Yet Recruiting
NCT05505994Phase 3

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Active Not Recruiting
NCT02518945Phase 3

Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes

Completed
NCT02725593Phase 3

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Completed
NCT01095666Phase 3

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Completed
NCT02096705Phase 3

Phase III Insulin Add-On Asia Regional Program - ST

Completed
NCT01095653Phase 3

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Completed
NCT00528372Phase 3

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8